These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 7828694)
21. Clinical efficacy and safety of budesonide Turbuhaler as compared to MDIs in children. Pedersen S J Aerosol Med; 1994; 7(Suppl 1):S67-71. PubMed ID: 10147083 [TBL] [Abstract][Full Text] [Related]
22. Systemic availability and lung deposition of budesonide via three different nebulizers in adults. Dahlström K; Thorsson L; Larsson P; Nikander K Ann Allergy Asthma Immunol; 2003 Feb; 90(2):226-32. PubMed ID: 12602671 [TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Thorsson L; Edsbäcker S; Källén A; Löfdahl CG Br J Clin Pharmacol; 2001 Nov; 52(5):529-38. PubMed ID: 11736861 [TBL] [Abstract][Full Text] [Related]
24. Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects. Nave R; Zech K; Bethke TD Eur J Clin Pharmacol; 2005 May; 61(3):203-8. PubMed ID: 15824911 [TBL] [Abstract][Full Text] [Related]
25. Gamma scintigraphic evaluation of a novel budesonide dry powder inhaler using a validated radiolabeling technique. Warren S; Taylor G; Smith J; Buck H; Parry-Billings M J Aerosol Med; 2002; 15(1):15-25. PubMed ID: 12006142 [TBL] [Abstract][Full Text] [Related]
26. Relative lung and total systemic bioavailability following inhalation from a metered dose inhaler compared with a metered dose inhaler attached to a large volume plastic spacer and a jet nebuliser. Silkstone VL; Corlett SA; Chrystyn H Eur J Clin Pharmacol; 2002 Jan; 57(11):781-6. PubMed ID: 11868799 [TBL] [Abstract][Full Text] [Related]
27. A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler. Agertoft L; Pedersen S J Allergy Clin Immunol; 1997 Jun; 99(6 Pt 1):773-80. PubMed ID: 9215245 [TBL] [Abstract][Full Text] [Related]
28. Effect of a spacer on total systemic and lung bioavailability in healthy volunteers and in vitro performance of the Symbicort Gillen M; Forte P; Svensson JO; Lamarca R; Burke J; Rask K; Larsdotter Nilsson U; Eckerwall G Pulm Pharmacol Ther; 2018 Oct; 52():7-17. PubMed ID: 30077809 [TBL] [Abstract][Full Text] [Related]
29. Importance of the inhalation device on the effect of budesonide. Agertoft L; Pedersen S Arch Dis Child; 1993 Jul; 69(1):130-3. PubMed ID: 8024295 [TBL] [Abstract][Full Text] [Related]
31. An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects. Kosoglou T; Hubbell J; Kantesaria B; Hanson ME; Cutler DL Clin Pharmacol Drug Dev; 2014 May; 3(3):229-34. PubMed ID: 27128613 [TBL] [Abstract][Full Text] [Related]
32. Efficacy, safety, and pharmacokinetics of budesonide/formoterol fumarate delivered via metered dose inhaler using innovative co-suspension delivery technology in patients with moderate-to-severe COPD. Kerwin EM; Siler TM; Arora S; Darken P; Rose E; Reisner C Int J Chron Obstruct Pulmon Dis; 2018; 13():1483-1494. PubMed ID: 29773947 [TBL] [Abstract][Full Text] [Related]
33. Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers. Wales D; Makker H; Kane J; McDowell P; O'Driscoll BR Chest; 1999 May; 115(5):1278-84. PubMed ID: 10334140 [TBL] [Abstract][Full Text] [Related]
34. Drug delivery from the Turbuhaler and Nebuhaler pressurized metered dose inhaler to various age groups of children with asthma. Agertoft L; Pedersen S; Nikander K J Aerosol Med; 1999; 12(3):161-9. PubMed ID: 10623332 [TBL] [Abstract][Full Text] [Related]
35. Budesonide inhaled via Turbuhaler: a more effective treatment for asthma than beclomethasone dipropionate via Rotahaler. Tjwa MK Ann Allergy Asthma Immunol; 1995 Aug; 75(2):107-11. PubMed ID: 7648372 [TBL] [Abstract][Full Text] [Related]
36. Scintigraphic evaluation of lung deposition with a novel inhaler device. Newman SP; Hirst PH; Pitcairn GR Curr Opin Pulm Med; 2001 Apr; 7 Suppl 1():S12-4. PubMed ID: 11385810 [TBL] [Abstract][Full Text] [Related]
37. [Budesonide administered via Turbuhaler and a nebulator]. Agertoft L; Pedersen SE Ugeskr Laeger; 1994 Jul; 156(28):4134-7. PubMed ID: 8066909 [TBL] [Abstract][Full Text] [Related]
38. Performance of Turbuhaler((R)) in Patients with Acute Airway Obstruction and COPD, and in Children with Asthma : Understanding the Clinical Importance of Adequate Peak Inspiratory Flow, High Lung Deposition, and Low In Vivo Dose Variability. Selroos O; Borgström L; Ingelf J Treat Respir Med; 2006; 5(5):305-15. PubMed ID: 16928144 [TBL] [Abstract][Full Text] [Related]
39. Pharmacoscintigraphic evaluation of lipid dry powder budesonide formulations for inhalation. Sebti T; Pilcer G; Van Gansbeke B; Goldman S; Michils A; Vanderbist F; Amighi K Eur J Pharm Biopharm; 2006 Aug; 64(1):26-32. PubMed ID: 16697169 [TBL] [Abstract][Full Text] [Related]